Literature DB >> 21781158

Decision-making under conditions of uncertainty-what can we learn from palivizumab?

Amanda Burls1, Josie Sandercock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21781158     DOI: 10.1111/j.1651-2227.2011.02426.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


× No keyword cloud information.
  1 in total

1.  A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom.

Authors:  Anthony Bentley; Ivana Filipovic; Katherine Gooch; Katharina Büsch
Journal:  Health Econ Rev       Date:  2013-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.